Companion Diagnostics for Oncology Market Trends and Will Generate New Growth Opportunities Status 2030 | QIAGEN N.V.; Thermo Fisher Scientific, Inc.

According to the report by Allied Market Research, titled, “Companion Diagnostics for Oncology Market by Product (Instruments, Consumables, and Software), Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Immunohistochemistry (IHC), In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH), and Other), Disease (Breast Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer, Leukemia, Melanoma, Prostate Cancer, and Others), and …